<VariationArchive RecordType="classified" VariationID="30737" VariationName="NM_014874.3:c.600_816del" VariationType="Deletion" Accession="VCV000030737" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2023-10-07" DateCreated="2016-09-04" MostRecentSubmission="2023-06-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39694" VariationID="30737">
      <GeneList>
        <Gene Symbol="MFN2" FullName="mitofusin 2" GeneID="9927" HGNC_ID="HGNC:16877" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>1p36.22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="11980444" stop="12013508" display_start="11980444" display_stop="12013508" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="12040237" stop="12073571" display_start="12040237" display_stop="12073571" Strand="+" />
          </Location>
          <OMIM>608507</OMIM>
          <Haploinsufficiency last_evaluated="2017-02-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MFN2">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-02-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MFN2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_014874.3:c.600_816del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p36.2</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>EX7-8DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_255t1" sequenceAccession="LRG_255t1">
            <Expression>LRG_255t1:c.600_816del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="608507.0018" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">The genomic location for allelic variant 08507.0018 will not be computed from alignment of the transcript sequence to the genome until there is experimental evidence for the genomic basis of the loss of exons 7 and 8.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014874.3:c.600_816del AND Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;" Accession="RCV000023715" Version="5">
        <ClassifiedConditionList TraitSetID="31969">
          <ClassifiedCondition DB="MedGen" ID="C4310725">Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-07-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014874.3:c.600_816del AND LIPOMATOSIS, MULTIPLE SYMMETRIC, WITH AXONAL PERIPHERAL NEUROPATHY" Accession="RCV003231109" Version="1">
        <ClassifiedConditionList TraitSetID="85195">
          <ClassifiedCondition>LIPOMATOSIS, MULTIPLE SYMMETRIC, WITH AXONAL PERIPHERAL NEUROPATHY</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-07-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-07-12" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2016-09-04" MostRecentSubmission="2023-06-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21715711</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26114802</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="85195" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="67815" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">LIPOMATOSIS, MULTIPLE SYMMETRIC, WITH AXONAL PERIPHERAL NEUROPATHY</ElementValue>
                <XRef Type="Allelic variant" ID="608507.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608507.0023" DB="OMIM" />
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="31969" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="35863" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth disease, axonal, type 2A2B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;</ElementValue>
                <XRef ID="MONDO:0014906" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMT2A2B</ElementValue>
                <XRef Type="MIM" ID="617087" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">MFN2 hereditary motor and sensory neuropathy (MFN2-HMSN) is a classic axonal peripheral sensorimotor neuropathy, inherited in either an autosomal dominant (AD) manner (~90%) or an autosomal recessive (AR) manner (~10%). MFN2-HMSN is characterized by more severe involvement of the lower extremities than the upper extremities, distal upper-extremity involvement as the neuropathy progresses, more prominent motor deficits than sensory deficits, and normal (&gt;42 m/s) or only slightly decreased nerve conduction velocities (NCVs). Postural tremor is common. Median onset is age 12 years in the AD form and age eight years in the AR form. The prevalence of optic atrophy is approximately 7% in the AD form and approximately 20% in the AR form.</Attribute>
                <XRef ID="NBK1511" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301684</ID>
                <ID Source="BookShelf">NBK1511</ID>
              </Citation>
              <XRef ID="C4310725" DB="MedGen" />
              <XRef ID="MONDO:0014906" DB="MONDO" />
              <XRef Type="MIM" ID="617087" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50262" SubmissionDate="2016-08-29" DateLastUpdated="2023-06-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608507.0018_CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2B, AUTOSOMAL RECESSIVE" title="MFN2, EX7-8DEL_CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2B, AUTOSOMAL RECESSIVE" />
        <ClinVarAccession Accession="SCV000045006" DateUpdated="2023-06-10" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-07-12">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the deletion of exons 7 and 8 in the MFN2 gene that was found in compound heterozygous state in 2 sibs of British descent with autosomal recessive inheritance of severe early-onset Charcot-Marie-Tooth disease-2A2B (CMT2A2B; 609260) by Polke et al. (2011), see 608507.0017.</Attribute>
              <Citation>
                <ID Source="PubMed">21715711</ID>
              </Citation>
              <XRef DB="OMIM" ID="609260" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Carr et al. (2015) reported 3 additional patients of UK ancestry with autosomal recessive early-onset axonal CMT2A2B due to compound heterozygous mutations in the MFN2 gene. All patients carried the exon 7-8 deletion on 1 allele, and haplotype analysis of these patients and the sibs reported by Polke et al. (2011) indicated a founder effect in this population. Two of the patients (families 2 and 3) carried a T362M (608507.0019) mutation on the other allele. The patient in family 4, who had multiple symmetric lipomatosis (MSL; 151800) with axonal peripheral neuropathy, carried a R707W (608507.0013) mutation on the other allele.</Attribute>
              <Citation>
                <ID Source="PubMed">26114802</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">21715711</ID>
              </Citation>
              <XRef DB="OMIM" ID="151800" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MFN2" />
          </GeneList>
          <Name>MFN2, EX7-8DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX7-8DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608507.0018" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2B, AUTOSOMAL RECESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7345098" SubmissionDate="2023-06-01" DateLastUpdated="2023-06-10" DateCreated="2023-06-10">
        <ClinVarSubmissionID localKey="608507.0018_LIPOMATOSIS, MULTIPLE SYMMETRIC, WITH AXONAL PERIPHERAL NEUROPATHY" title="MFN2, EX7-8DEL_LIPOMATOSIS, MULTIPLE SYMMETRIC, WITH AXONAL PERIPHERAL NEUROPATHY" />
        <ClinVarAccession Accession="SCV003929411" DateUpdated="2023-06-10" DateCreated="2023-06-10" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-07-12">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the deletion of exons 7 and 8 in the MFN2 gene that was found in compound heterozygous state in 2 sibs of British descent with autosomal recessive inheritance of severe early-onset Charcot-Marie-Tooth disease-2A2B (CMT2A2B; 609260) by Polke et al. (2011), see 608507.0017.</Attribute>
              <Citation>
                <ID Source="PubMed">21715711</ID>
              </Citation>
              <XRef DB="OMIM" ID="609260" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Carr et al. (2015) reported 3 additional patients of UK ancestry with autosomal recessive early-onset axonal CMT2A2B due to compound heterozygous mutations in the MFN2 gene. All patients carried the exon 7-8 deletion on 1 allele, and haplotype analysis of these patients and the sibs reported by Polke et al. (2011) indicated a founder effect in this population. Two of the patients (families 2 and 3) carried a T362M (608507.0019) mutation on the other allele. The patient in family 4, who had multiple symmetric lipomatosis (MSL; 151800) with axonal peripheral neuropathy, carried a R707W (608507.0013) mutation on the other allele.</Attribute>
              <Citation>
                <ID Source="PubMed">26114802</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">21715711</ID>
              </Citation>
              <XRef DB="OMIM" ID="151800" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MFN2" />
          </GeneList>
          <Name>MFN2, EX7-8DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX7-8DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608507.0018" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">LIPOMATOSIS, MULTIPLE SYMMETRIC, WITH AXONAL PERIPHERAL NEUROPATHY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="50262" TraitType="Disease" MappingType="Name" MappingValue="CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2B, AUTOSOMAL RECESSIVE" MappingRef="Preferred">
        <MedGen CUI="C4310725" Name="Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7345098" TraitType="Disease" MappingType="Name" MappingValue="LIPOMATOSIS, MULTIPLE SYMMETRIC, WITH AXONAL PERIPHERAL NEUROPATHY" MappingRef="Alternate">
        <MedGen CUI="None" Name="LIPOMATOSIS, MULTIPLE SYMMETRIC, WITH AXONAL PERIPHERAL NEUROPATHY" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

